DDrare: Database of Drug Development for Rare Diseases

Tabalumab auto-injector (DrugBank: Tabalumab)

2 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	1
49	Systemic lupus erythematosus	1

46. Malignant rheumatoid arthritis [ 4,183 clinical trials, 2,538 drugs, (DrugBank: 401 drugs), 183 drug target genes, 219 drug target pathways]

Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 4,183 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01676701 (ClinicalTrials.gov)	September 2012	29/8/2012	Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)	Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate	Rheumatoid Arthritis	Drug: Tabalumab Auto-Injector;Drug: Tabalumab Prefilled Syringe	Eli Lilly and Company	NULL	Terminated	18 Years	N/A	All	8	Phase 3	United States;Argentina;Czechia;Poland;Puerto Rico;Russian Federation;Czech Republic

49. Systemic lupus erythematosus [ 827 clinical trials, 638 drugs, (DrugBank: 168 drugs), 108 drug target genes, 191 drug target pathways]

Searched query = "Systemic lupus erythematosus", "SLE"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 827 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02041091 (ClinicalTrials.gov)	January 2014	17/1/2014	A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus	Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus	Lupus Erythematosus, Systemic	Drug: Tabalumab Auto-Injector;Drug: Tabalumab Prefilled Syringe	Eli Lilly and Company	NULL	Terminated	18 Years	N/A	All	226	Phase 3	United States;Korea, Republic of;Puerto Rico;Mexico